LOOK WHO’S SELLING NTMD
The company’s chief medical officer exercised options to buy 60,000 shares last week at $1.16 and sold them for $21.94. In December, he sold 30,000 shares at $20.63 that he had acquired by exercising options at 8 cents a share. Meanwhile, the company itself has filed a ‘shelf registration’ to sell up to a quarter billion dollars worth of its stock and/or bonds – not an insignificant sum for a company this size.
Neither of these pieces of information is ‘dispositive,’ as they say – ‘finally determinative.’ But taken with the IMS prescription data suggesting that only a few hundred prescriptions for BiDil may have been written thus far (while expenses of more than $100 million for the year have been budgeted), one imagines that the chief medical officer, and the company, may be on to a good thing.
(A shelf registration doesn’t require a company to issue new securities, but puts it in a position to do so without regulatory delay.)
The stock closed last night at $19.90, for an overall market valuation, with just over 30 million shares outstanding, of $600 million.
Anything’s possible, but . . . don’t sell your puts.
BEFORE WE ATTACK IRAN . . .
The author argues that it’s a serious situation, but hardly a crisis.
Quote of the Day
If Patrick Henry thought that taxation without representation was bad, he should see how bad it is with representation.~The Old Farmer's Almanac
Request email delivery
- Aug 4:
But First . . .
- Aug 3:
Swimming To Israel On EVLO Cap Gains For Norman Lear’s Birthday
- Jul 31:
How To Tax Wealth — Your Feedback
- Jul 28:
How To Tax Wealth
- Jul 27:
Newsweek: Teachers Union Has Become A Public Menace
- Jul 26:
Moses . . . R.I.P.
- Jul 23:
PRKR, COVID, CLIMATE, AND MORE!
- Jul 22:
Macron and Maddow
- Jul 21:
Field Of Dreams
- Jul 20:
Waste Not, Want Not; A Truly Great Man
- Aug 4: